Tech Center 1600 • Art Units: 1627 1629
This examiner grants 61% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18285812 | GPR119 AGONISTS | Non-Final OA | Kallyope, Inc. |
| 18720571 | COVALENTLY BINDING INHIBITORS OF G12S, G12D AND/OR G12E MUTANTS OF K-RAS GTPASE | Non-Final OA | The Regents of the University of California |
| 19257262 | PI4-Kinase Inhibitors and Methods of Using the Same | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 18800559 | COMPOUNDS AND COMPOSITIONS FOR MODULATING THE ACTIVITY OF ERK | Non-Final OA | Novartis AG |
| 18730214 | IMMUNOMODULATORY LIPIDS AND USES THEREOF | Non-Final OA | The General Hospital Corporation |
| 18802257 | PROCESSES FOR THE PREPARATION OF 1,2,3,5,6,7-HEXAHYDRO-S-INDACENE DERIVATAIVES | Non-Final OA | Hoffmann-La Roche Inc. |
| 18068407 | AMIDOPYRIMIDONE DERIVATIVES | Non-Final OA | Hoffmann-La Roche Inc. |
| 18800769 | SULFONATO RESORCINARENE-COMPLEXED FLUOROQUINOLONES AND METHODS OF USE | Non-Final OA | University of Cincinnati |
| 18778440 | DIAGNOSIS OF IMMUNITY REDUCTION THROUGH INTESTINAL MICROFLORA ANALYSIS OF STOMACH CANCER PATIENTS, AND THERAGNOSTIC COMPOSITION USING INTESTINAL MICROFLORA | Non-Final OA | THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION |
| 17919726 | COMBINATION THERAPY OF ARTEMISININ-RELATED COMPOUNDS AND HISTONE DEACETYLASE INHIBITORS FOR TREATMENT OF HPV-RELATED BENIGN, PREMALIGNANT, AND MALIGNANT DISEASES | Final Rejection | Georgetown University |
| 18742267 | COMPOSITIONS AND METHODS RELATING TO USE OF PHOSPHATIDIC ACID TO RESCUE FETAL ALCOHOL SPECTRUM DISORDER (FASD) GROWTH RESTRICTION AND BLOOD VESSEL CONSTRICTION | Non-Final OA | Wayne State University |
| 18725842 | Use of L-cysteine for improving the structure and function of gastric mucosa | Non-Final OA | Biohit Oyj |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy